Trials / Completed
CompletedNCT03369535
Metabonomics to Investigate Effects of Healthy Diets on Blood Pressure: the OmniHeart Study
Urinary Metabolic Phenotyping of Diet-cardiovascular Disease Risk Associations: the OmniHeart Feeding Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 158 (actual)
- Sponsor
- University of Kent · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To compare the urinary metabolomes on individuals undergone three different healthy diets--a carbohydrate-rich diet, a protein-rich diet, or a diet rich in unsaturated fat.
Detailed description
BACKGROUND: This study based on the OmniHeart dietary intervention study, a randomized, three period cross-over feeding study that compared the effects on blood pressure and plasma lipids of three DASH-like diets: a carbohydrate-rich (CARB) diet pattern, a rich in protein (PROT) and a rich in unsaturated (MUFA) fat, predominantly monounsaturated fat diet (see full details of OmniHeart dietary intervention https://clinicaltrials.gov/ct2/show/record/NCT00051350). This metabonomic study aims to evaluate the feasibility of identifying individuals showing variation in clinical response to three different healthy diets, with the purpose of reducing cardiovascular disease (CVD) risk, using proton nuclear magnetic resonance (NMR) based metabolic phenotyping approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CARB rich diet | Consumed CARB rich diet for 6 weeks with a washout period of at least 2 weeks before the next intervention |
| OTHER | MUFA rich diet | Consumed MUFA rich diet for 6 weeks with a washout period of at least 2 weeks before the next intervention |
| OTHER | PROT rich diet | Consumed PROT rich diet for 6 weeks with a washout period of at least 2 weeks before the next intervention |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2015-07-31
- Completion
- 2017-12-01
- First posted
- 2017-12-12
- Last updated
- 2017-12-12
Source: ClinicalTrials.gov record NCT03369535. Inclusion in this directory is not an endorsement.